SCHEMBL7351201

SCHEMBL7351201

CCCN(CCC)OC(=O)CC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
FFAR3 O14843 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
KDM5A P29375 3/20 0.33
KDM4C Q9H3R0 2/20 0.33
CA12 O43570 2/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
TSHR P16473 2/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7353574 0.89 MGAM (0.40) CA12CA2CA9TSHRMGAM
SCHEMBL10801654 0.83 MGAM (0.46) CA12CA2CA9TSHRMGAM
SCHEMBL5926969 0.82 KDM6B (0.37) KDM6BKDM5CEGLN1PHF8KDM2A
Hydrochloric Acid SCHEMBL5514211 0.80 KDM6B (0.35) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL28466573 0.79 KDM6B (0.43) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL28599459 0.79 ALDH1A1 (0.40) FFAR3CA12CA2CA9TSHR
SCHEMBL28245785 0.77 ALDH1A1 (0.50) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL29049114 0.77 CA12 (0.37) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL28444877 0.74 CA12 (0.39) CA12CA2CA9TSHRALDH1A1
SCHEMBL3267506 0.72 PHF8 (0.62) KDM6BKDM5CEGLN1PHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed